Clinical Cardiac Electrophysiology Exam Prep
Free practice questions

Free CCEP Practice Questions

10 exam-style questions with answers and explanations, straight from our 1,030-question bank. Tap an answer to check yourself. When you're ready, take the scored version in the free practice test.

Start the free practice test → ★★★★★4.9/5 from 2,400+ candidates · No signup

These 10 free CCEP questions are organized by exam domain, so you can see how each part of the Clinical Cardiac Electrophysiology blueprint is tested. Reveal the answer and explanation under each question.

Domain 1: Basic Physiology, Anatomy, Pharmacology, and Genetics (20%) - Cellular electrophysiology (4%): action potentials, ion channels and currents, receptors, gap junctions; Cardiac anatomy (<2%); Cardiac tissue physiology (10%): refractory periods, neuronal control-sympathetic nervous system and catecholamines, atrioventricular (AV) and ventriculoatrial (VA) conduction delay and block, mechanisms of arrhythmias, electrical and structural remodeling, repolarization-dispersion and reserve, other physiologic phenomena (retrograde block, ACE inhibitors, fractionated electrograms, pseudonormalization); Pharmacology (4%): pharmacokinetics, use and reverse use dependence, properties of antiarrhythmic agents; Genetics (<2%): ion channels, non-ion channels.

Question 1

Greater antiarrhythmic effect at slower heart rates describes what property?

Show answer & explanation

Correct answer: A - Reverse use dependence

Domain 2: Clinical Arrhythmias: Core Concepts (5%) - Recognition of artifact (<2%); pacing, signal recording, and mapping systems (electrophysiology laboratory) (<2%); noninvasive testing (<2%): indications, tilt-table testing, interpretation of wide QRS tachycardias, ambulatory electrocardiographic monitoring; invasive electrophysiologic testing (2%): indications, interpretation; biophysics of ablation (<2%); transseptal catheterization and pericardial access (<2%); cardiac and intracardiac imaging (<2%).

Question 2

For rare unexplained syncope episodes, which test maximizes rhythm capture?

Show answer & explanation

Correct answer: C - Long-term ambulatory monitoring

Domain 3: Clinical Arrhythmias: Bradycardias (5%) - Sinus node dysfunction (<2%); AV block (3%): AV nodal block, infranodal AV block; escape and accelerated rhythms (<2%).

Question 3

Progressive PR prolongation followed by a dropped beat indicates what?

Show answer & explanation

Correct answer: B - Mobitz I second-degree AV block

Domain 4: Clinical Arrhythmias: Atrial (12%) - Atrial fibrillation (5%): mechanism and etiology, ECG monitors and remote monitoring, pharmacologic treatment, postoperative atrial fibrillation, stroke prevention, cardioversion, catheter ablation, surgical ablation, AV junction ablation; Atrial flutter (4%): ECG monitors and remote monitoring, pharmacologic treatment, stroke prevention, cardioversion, cavotricuspid isthmus (CTI)-dependent atrial flutter, atypical right atrial flutter, atypical left atrial flutter; Focal atrial tachycardias (3%): ECG monitors and remote monitoring, pharmacologic treatment, catheter ablation.

Question 4

In atrial fibrillation, stroke prevention decisions should primarily be based on what?

Show answer & explanation

Correct answer: C - Thromboembolic risk assessment

Domain 5: Clinical Arrhythmias: Supraventricular Tachycardias (15%) - Accessory pathway syndromes (9%): ECG monitors and remote monitoring, pharmacologic treatment, electrophysiologic studies in ventricular preexcitation, electrophysiologic studies in orthodromic AVRT (typical and atypical pathways), electrophysiologic studies in antidromic AVRT (typical and atypical pathways), ablation of accessory pathways, fasciculoventricular pathways, multiple pathways; AV nodal reentry tachycardia (AVNRT) (5%): typical AVNRT (ECGs, pharmacologic treatment, intracardiac recordings, and ablation), atypical AVNRT (ECGs, pharmacologic treatment, intracardiac recordings, and ablation); Junctional tachycardias (<2%): ECG monitors and remote monitoring, pharmacologic treatment, interpretation of electrophysiology recordings, ablation; Multiple SVT mechanisms (<2%): ECG monitors and remote monitoring, pharmacologic treatment, interpretation of electrophysiology recordings, ablation.

Question 5

Orthodromic AVRT is defined by which circuit?

Show answer & explanation

Correct answer: A - Antegrade AV node with retrograde accessory pathway

Question 6

A slow-fast AV nodal circuit represents which arrhythmia?

Show answer & explanation

Correct answer: D - Typical AVNRT

Domain 6: Clinical Arrhythmias: Ventricular (15%) - ECGs and ambulatory monitoring (3%): ambulatory monitor recordings, ECG localization-premature ventricular complexes (PVC) and VT; Core concepts (5%): indications for invasive electrophysiologic studies, interpretation of intracardiac recordings, pharmacologic treatment, principles of entrainment; Ventricular tachycardias and ischemic heart disease (3%): physiology, endocardial ablation, epicardial ablation, arrhythmias in patients with a left ventricular assist device (LVAD), hemodynamic support during ablation; Ventricular tachycardias and nonischemic cardiomyopathy (<2%): physiology, endocardial ablation, epicardial ablation, arrhythmias in patients with a left ventricular assist device (LVAD), hemodynamic support during ablation; Ventricular tachycardias and premature ventricular complexes and the normal heart (2%): physiology, endocardial ablation, epicardial ablation; Ventricular fibrillation and polymorphic ventricular tachycardias (<2%): physiology, ECG monitors and remote monitoring, pharmacologic treatment, bradycardia-dependent, drug-induced, ischemic, indications for invasive electrophysiologic studies, ablation.

Question 7

Scar-related monomorphic VT is most commonly caused by what mechanism?

Show answer & explanation

Correct answer: D - Reentry around areas of myocardial scar

Domain 7: Devices (20%) - General concepts (<2%): electromagnetic interference, biophysics and bioengineering, lead extraction, infection, automatic external and wearable defibrillators; Pacemakers (6%): indications, implantation techniques, programming and follow-up, complications, leadless pacing; Implantable cardioverter-defibrillator (ICD) therapy (7%): indications, implantation techniques, ECG monitors and remote monitoring, programming, follow-up, complications, subcutaneous implantable defibrillator; Cardiac resynchronization (5%): indications, implantation techniques, ECG monitors and remote monitoring, programming, leads, follow-up, complications; Insertable loop recorders (<2%).

Question 8

Which pacemaker programming strategy reduces unnecessary ventricular pacing in patients with intact AV conduction?

Show answer & explanation

Correct answer: B - Enable ventricular pacing minimization algorithms

Question 9

Which device specifically detects and treats malignant ventricular arrhythmias?

Show answer & explanation

Correct answer: A - Implantable cardioverter-defibrillator

Domain 8: Clinical Scenarios and Syndromes (8%) - Common scenarios (2%): syncope, palpitations, sudden cardiac death, ethics, manage advisories and recalls; Specific syndromes (6%): long QT syndrome, Brugada syndrome, catecholaminergic polymorphic VT, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, sarcoidosis, other arrhythmia substrates (musculoskeletal, short QT syndrome, early repolarization syndrome), arrhythmias in pregnancy, arrhythmias in athletes, congenital heart disease.

Question 10

Exercise-triggered polymorphic VT in a young person with normal structure suggests?

Show answer & explanation

Correct answer: B - Catecholaminergic polymorphic VT

That's 10 of 1,030

The full bank has 1,020 more CCEP questions with explanations.

Continue in the free practice test →

View plans